目次

Table of Content

1. Introduction To Bicycle Toxin Conjugates
1.1 Overview
1.2 History and Evolution

2. Bicycle Toxin Conjugates - Mechanism Of Action

3. Global Bicycle Toxin Conjugates Research and Market Trends By Indication
3.1 Cancer
3.2 Viral Diseases

4. Bicycle Toxin Conjugates - Proprietary Platforms

5. Global Bicyclic Toxin Conjugates Clinical Trials Overview
5.1 By Company
5.2 By Indication
5.3 By Location
5.4 By Phase

6. Global Bicyclic Toxin Conjugates Clinical Pipeline By Company, Indication and Phase
6.1 Phase-I/II
6.2 Phase-III

7. Global Bicycle Toxin Conjugates Current and Future Market Trends Outlook
7.1 Current Market Trends, Developments and Clinical Trials Assessment
7.2 Future Commercialization Opportunity

8. Global Bicycle Toxin Conjugates Research and Market Trends By Region
8.1 US
8.2 EU
8.3 UK

9. Global Bicycle Toxin Conjugates Market Dynamics
9.1 Market Drivers and Commercial Opportunities
9.2 Market Challenges and Restraints

10. Competitive Landscape
10.1 Bicycle Therapeutics

List of Figures & Tables
Figure 1-1: Bicycle Toxin Conjugate - Structure
Figure 2-1: Bicycle Toxin Conjugates - Mechanism Of Action
Figure 3-1: Zelenectide Pevedotin - Structure
Figure 3-2: Duravelo-1 Phase 1/2 (NCT04561362) Study - Initiation and Completion Year
Figure 3-3: Duravelo-2 Phase 2/3 (NCT06225596) Study - Initiation and Completion Year
Figure 3-4: Duravelo-3 Phase 2 (NCT06840483) Study - Initiation and Completion Year
Figure 3-5: Duravelo-4 Phase 2 (NCT06933329) Study - Initiation and Completion Year
Figure 3-6: BT5528 - Structure
Figure 3-7: BT5528-100 Phase 1/2 Study - Initiation and Completion Year
Figure 3-8: BT1718 - Structure
Figure 4-1: Bicycles - Advantages
Figure 4-2: Bicycles - Key Properties
Figure 5-1: Global - Bicyclic Toxin Conjugates Clinical Trials By Company (Number), 2025
Figure 5-2: Global - Bicyclic Toxin Conjugates Clinical Trials By Indication (Number), 2025
Figure 5-3: Global - Bicyclic Toxin Conjugates Clinical Trials By Location (Number), 2025
Figure 5-4: Global - Bicyclic Toxin Conjugates Clinical Trials By Phase (Number), 2025
Figure 7-1: Global Bicycle Toxin Conjugates Market - Future Opportunities
Figure 9-1: Bicycle Toxin Conjugates Market - Drivers and Opportunities
Figure 9-2: Bicycle Toxin Conjugates Market - Challenges and Restraints
Table 8-1: US - Ongoing Clinical Trials for Bicycle Toxin Conjugates
Table 8-2: EU - Ongoing Clinical Trials for Bicycle Toxin Conjugates
Table 8-3: UK - Ongoing Clinical Trials for Bicycle Toxin Conjugates